Strides Pharma posts ₹102-cr profit in first quarter

Our Bureau Bengaluru | Updated on August 05, 2020 Published on August 05, 2020

Strides Pharma Sciences Limited has posted ₹101.84 crore profit for the first-quarter of 2020-21 as against ₹2.91 crore posted last year.

The company’s revenue was up 14.08 per cent for Q1 at ₹794.10 crore as against ₹696.05 crore posted last year. EPS for the quarter stood at ₹11.56 compared with ₹3.11 last year.

Commenting on the performance, R Ananthanarayanan, Managing Director & CEO, saud, “Coming out of a challenging Q4 FY20 due to Ranitidine withdrawal, Strides has started FY21 on a positive note. We have reported strong performance across all our business in Q1 FY21 despite significant disruptions and ambiguity in the business environment due to Covid-19.”

He added “Our regulated markets growth was 22 per cent quarter-on-quarter and our emerging markets are now returning to growth after several quarters.”

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on August 05, 2020
This article is closed for comments.
Please Email the Editor